Found: 8
Select item for more details and to access through your institution.
A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 605, doi. 10.2147/JPR.S237833
- By:
- Publication type:
- Article
Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abusedeterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain.
- Published in:
- Journal of Pain Research, 2015, v. 8, p. 623, doi. 10.2147/JPR.S83930
- By:
- Publication type:
- Article
A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain.
- Published in:
- Journal of Pain Research, 2014, v. 7, p. 669, doi. 10.2147/JPR.S71536
- By:
- Publication type:
- Article
Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain.
- Published in:
- Journal of Pain Research, 2013, v. 6, p. 319, doi. 10.2147/JPR.S39980
- By:
- Publication type:
- Article
Evaluation of Quality of Life, Functioning, Disability, and Work/School Productivity Following Treatment with an Extended-Release Hydrocodone Tablet Formulated with Abuse-Deterrence Technology: A 12-month Open-label Study in Patients with Chronic Pain.
- Published in:
- Pain Practice, 2017, v. 17, n. 2, p. 229, doi. 10.1111/papr.12433
- By:
- Publication type:
- Article
Psychotherapy trainees' epistemological assumptions influencing research-practice integration.
- Published in:
- Research in Psychotherapy: Psychopathology, Process & Outcome, 2019, v. 22, n. 3, p. 344, doi. 10.4081/ripppo.2019.397
- By:
- Publication type:
- Article
Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211032320
- By:
- Publication type:
- Article
Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211032320
- By:
- Publication type:
- Article